459 related articles for article (PubMed ID: 26909861)
21. A validated metabolomic signature for colorectal cancer: exploration of the clinical value of metabolomics.
Farshidfar F; Weljie AM; Kopciuk KA; Hilsden R; McGregor SE; Buie WD; MacLean A; Vogel HJ; Bathe OF
Br J Cancer; 2016 Sep; 115(7):848-57. PubMed ID: 27560555
[TBL] [Abstract][Full Text] [Related]
22. Analytical validation of a novel multiplex test for detection of advanced adenoma and colorectal cancer in symptomatic patients.
Dillon R; Croner LJ; Bucci J; Kairs SN; You J; Beasley S; Blimline M; Carino RB; Chan VC; Cuevas D; Diggs J; Jennings M; Levy J; Mina G; Yee A; Wilcox B
J Pharm Biomed Anal; 2018 May; 154():85-94. PubMed ID: 29533862
[TBL] [Abstract][Full Text] [Related]
23. Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer.
Church TR; Wandell M; Lofton-Day C; Mongin SJ; Burger M; Payne SR; Castaños-Vélez E; Blumenstein BA; Rösch T; Osborn N; Snover D; Day RW; Ransohoff DF;
Gut; 2014 Feb; 63(2):317-25. PubMed ID: 23408352
[TBL] [Abstract][Full Text] [Related]
24. Detection of autoantibodies against Rabphilin-3A-like protein as a potential biomarker in patient's sera of colorectal cancer.
Chen JS; Kuo YB; Chou YP; Chan CC; Fan CW; Chen KT; Huang YS; Chan EC
Clin Chim Acta; 2011 Jul; 412(15-16):1417-22. PubMed ID: 21536019
[TBL] [Abstract][Full Text] [Related]
25. LGALS4, CEACAM6, TSPAN8, and COL1A2: Blood Markers for Colorectal Cancer-Validation in a Cohort of Subjects With Positive Fecal Immunochemical Test Result.
Rodia MT; Solmi R; Pasini F; Nardi E; Mattei G; Ugolini G; Ricciardiello L; Strippoli P; Miglio R; Lauriola M
Clin Colorectal Cancer; 2018 Jun; 17(2):e217-e228. PubMed ID: 29352642
[TBL] [Abstract][Full Text] [Related]
26. Serum netrin-1 as a biomarker for colorectal cancer detection.
Li B; Shen K; Zhang J; Jiang Y; Yang T; Sun X; Ma X; Zhu J
Cancer Biomark; 2020; 28(3):391-396. PubMed ID: 32474463
[TBL] [Abstract][Full Text] [Related]
27. Measurement of the IgM and IgG Autoantibody Immune Responses in Human Serum has High Predictive Value for the Presence of Colorectal Cancer.
Fitzgerald S; O'Reilly JA; Wilson E; Joyce A; Farrell R; Kenny D; Kay EW; Fitzgerald J; Byrne B; Kijanka GS; O'Kennedy R
Clin Colorectal Cancer; 2019 Mar; 18(1):e53-e60. PubMed ID: 30366678
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of paraneoplastic antigens reveals TRIM21 autoantibodies as biomarker for early detection of ovarian cancer in combination with autoantibodies to NY-ESO-1 and TP53.
Hurley LC; Levin NK; Chatterjee M; Coles J; Muszkat S; Howarth Z; Dyson G; Tainsky MA
Cancer Biomark; 2020; 27(3):407-421. PubMed ID: 32083570
[TBL] [Abstract][Full Text] [Related]
29. Multiple serological biomarkers for colorectal cancer detection.
Chan CC; Fan CW; Kuo YB; Chen YH; Chang PY; Chen KT; Hung RP; Chan EC
Int J Cancer; 2010 Apr; 126(7):1683-90. PubMed ID: 19795454
[TBL] [Abstract][Full Text] [Related]
30. Quantitative proteomic analysis exploring progression of colorectal cancer: Modulation of the serpin family.
Peltier J; Roperch JP; Audebert S; Borg JP; Camoin L
J Proteomics; 2016 Oct; 148():139-48. PubMed ID: 27492143
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of serum autoantibodies against tumor-associated antigens as biomarkers in lung cancer.
Li P; Shi JX; Xing MT; Dai LP; Li JT; Zhang JY
Tumour Biol; 2017 Oct; 39(10):1010428317711662. PubMed ID: 29022480
[TBL] [Abstract][Full Text] [Related]
32. Tumor-associated autoantibody signature for the early detection of gastric cancer.
Zayakin P; Ancāns G; Siliņa K; Meistere I; Kalniņa Z; Andrejeva D; Endzeliņš E; Ivanova L; Pismennaja A; Ruskule A; Doniņa S; Wex T; Malfertheiner P; Leja M; Linē A
Int J Cancer; 2013 Jan; 132(1):137-47. PubMed ID: 22684876
[TBL] [Abstract][Full Text] [Related]
33. Predictive Levels of CD24 in Peripheral Blood Leukocytes for the Early Detection of Colorectal Adenomas and Adenocarcinomas.
Kraus S; Shapira S; Kazanov D; Naumov I; Moshkowitz M; Santo E; Galazan L; Geva R; Shmueli E; Hallack A; Arber N
Dis Markers; 2015; 2015():916098. PubMed ID: 26078485
[TBL] [Abstract][Full Text] [Related]
34. A combination of serum markers for the early detection of colorectal cancer.
Wild N; Andres H; Rollinger W; Krause F; Dilba P; Tacke M; Karl J
Clin Cancer Res; 2010 Dec; 16(24):6111-21. PubMed ID: 20798228
[TBL] [Abstract][Full Text] [Related]
35. A blood-based biomarker panel for stratifying current risk for colorectal cancer.
Marshall KW; Mohr S; Khettabi FE; Nossova N; Chao S; Bao W; Ma J; Li XJ; Liew CC
Int J Cancer; 2010 Mar; 126(5):1177-86. PubMed ID: 19795455
[TBL] [Abstract][Full Text] [Related]
36. Non-coding RNAs as Biomarkers for Colorectal Cancer Screening and Early Detection.
Slaby O
Adv Exp Med Biol; 2016; 937():153-70. PubMed ID: 27573899
[TBL] [Abstract][Full Text] [Related]
37. Epigenome-wide discovery and evaluation of leukocyte DNA methylation markers for the detection of colorectal cancer in a screening setting.
Heiss JA; Brenner H
Clin Epigenetics; 2017; 9():24. PubMed ID: 28270869
[TBL] [Abstract][Full Text] [Related]
38. Autoantibodies against tumor-associated antigens in the early detection of lung cancer.
Dai L; Tsay JC; Li J; Yie TA; Munger JS; Pass H; Rom WN; Zhang Y; Tan EM; Zhang JY
Lung Cancer; 2016 Sep; 99():172-9. PubMed ID: 27565936
[TBL] [Abstract][Full Text] [Related]
39. A plasma microRNA panel for early detection of colorectal cancer.
Wang S; Xiang J; Li Z; Lu S; Hu J; Gao X; Yu L; Wang L; Wang J; Wu Y; Chen Z; Zhu H
Int J Cancer; 2015 Jan; 136(1):152-61. PubMed ID: 23456911
[TBL] [Abstract][Full Text] [Related]
40. A novel plasma based early colorectal cancer screening assay base on methylated SDC2 and SFRP2.
Zhao G; Ma Y; Li H; Li S; Zhu Y; Liu X; Xiong S; Liu Y; Miao J; Fei S; Zheng M; Zhao X
Clin Chim Acta; 2020 Apr; 503():84-89. PubMed ID: 31962098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
